Labeling DNA Probes
Targeted Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 13, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Seulki Lee1, Jin Xie, Xiaoyuan Chen
1Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), 31 Center Dr, Suite 1C14, Bethesda, MD 20892-2281, USA. Seulki.Lee@nih.gov
Developing sensitive molecular probes for cancer imaging is challenging. Novel activatable imaging probes offer high-resolution, low-background cancer detection by amplifying signals in real-time based on biological cues.
06:46Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
06:51Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
Published on: November 14, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: